MiR-19a-3p: a potential biomarker for predicting cardiac risk in anderson-fabry disease
Yiming Zhang, Hongqiang Yang, Shuping Wang, Chengcheng Yi, Yongxiang Wang, Ming Bai, Zheng Zhang · 2026
Read MiR-19a-3p: a potential biomarker for predicting cardiac risk in anderson-fabry disease by Yiming Zhang, Hongqiang Yang, Shuping Wang, Chengcheng Yi, Yongxiang Wang, Ming Bai, Zheng Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13540881.txt.
Description
Yiming Zhang and colleagues tested a tiny RNA signal as a heart-risk marker in Anderson-Fabry disease. Published in 2026, the study set 60 patients with the rare passed-down disorder beside 60 healthy controls. The disorder stems from a faulty gene that lets fatty waste pile up in nerves, heart, kidneys, and skin, driving organ damage.
Just over half the patients showed heart damage with clear shape changes. The RNA signal ran lower in patients and in those with heart muscle disease, spotting both the disorder and its heart injury with high hit rates. Higher injury tracked lower signal levels, and the signal stood out on its own as a shield against heart damage. The authors propose it as a strong marker choice for heart risk in this illness.
Catalog record
| CREATOR | Yiming Zhang, Hongqiang Yang, Shuping Wang, Chengcheng Yi, Yongxiang Wang, Ming Bai, Zheng Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |